4//SEC Filing
Mauro David J 4
Accession 0001601830-24-000215
CIK 0001601830other
Filed
Nov 18, 7:00 PM ET
Accepted
Nov 19, 6:26 PM ET
Size
7.9 KB
Accession
0001601830-24-000215
Insider Transaction Report
Form 4
Mauro David J
Chief Medical Officer
Transactions
- Tax Payment
Class A Common Stock
2024-11-15$6.17/sh−4,187$25,855→ 225,429 total
Holdings
- 99,537
Stock Option (Right to Buy)
Exercise: $10.09Exp: 2034-02-09→ Class A Common Stock (0 underlying) - 381,426
Stock Option (Right to Buy)
Exercise: $8.77Exp: 2033-06-01→ Class A Common Stock (0 underlying)
Footnotes (3)
- [F1]Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units.
- [F2]The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2024, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.
- [F3]This option vests as to one fourth (1/4th) of the shares subject to the option on June 1, 2024, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter subject to Reporting Person's continued service to the Issuer through each such vesting date.
Documents
Issuer
RECURSION PHARMACEUTICALS, INC.
CIK 0001601830
Entity typeother
Related Parties
1- filerCIK 0001621172
Filing Metadata
- Form type
- 4
- Filed
- Nov 18, 7:00 PM ET
- Accepted
- Nov 19, 6:26 PM ET
- Size
- 7.9 KB